|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization expense | |||||
| Deferred income taxes, net | |||||
| (Gain) loss on derivatives | |||||
| Loss on extinguishment of debt | |||||
| Provision for bad debts and inventory obsolescence | |||||
| Gain on involuntary conversion of assets | |||||
| Share-based compensation expense | |||||
| Net foreign currency adjustments on euro-denominated debt | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable, net | |||||
| Inventories | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued expenses and other liabilities | |||||
| Advance ticket sales | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Additions to property and equipment, net | |||||
| Cash paid on settlement of derivatives | |||||
| Acquisition, net of cash acquired | |||||
| Other | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Repayments of long-term debt | |||||
| Proceeds from long-term debt | |||||
| Due to NCLH, net | |||||
| Contribution from NCLH | |||||
| Net share settlement of restricted share units | |||||
| Early redemption premium | |||||
| Deferred financing fees | |||||
| Net cash provided by (used in) financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
Loading...